Beam Therapeutics Inc. (BEAM)
NASDAQ · Healthcare
Beam Therapeutics Inc. annual/quarterly shareholder equity history from 2019 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Beam Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 1.24B, a 68.82% increase year-over-year.
- Beam Therapeutics Inc. shareholder equity for 2025 were 1.24B, a 68.82% increase from 2024.
- Beam Therapeutics Inc. shareholder equity for 2024 were 733.5M, a 25.25% decrease from 2023.
- Beam Therapeutics Inc. shareholder equity for 2023 were 981.3M, a 33.79% increase from 2022.
- Beam Therapeutics Inc. shareholder equity for 2022 were 733.5M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Beam Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $1,238 |
| 2024 | $734 |
| 2023 | $981 |
| 2022 | $733 |
| 2021 | $827 |
| 2020 | $246 |
| 2019 | $-201 |
| Beam Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $1,238 |
| 2024-12-31 | $734 |
| 2023-12-31 | $981 |
| 2022-12-31 | $733 |
| 2021-12-31 | $827 |
| 2020-12-31 | $246 |
| 2019-12-31 | $-201 |
Beam Therapeutics Inc. Shareholder Equity — FAQ
Beam Therapeutics Inc. (BEAM) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BEAM's shareholder equity history?
The chart and table above show Beam Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.